[{"address1": "238 Main Street", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 327 8775", "website": "https://beamtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease; BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. It also intends to develop BEAM-103, an anti-CD117 monoclonal antibody, and BEAM-104, a cell therapy for development in sickle cell disease and beta-thalassemia; and BEAM-201 and other potential ex vivo CAR-T therapies. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 510, "companyOfficers": [{"maxAge": 1, "name": "Mr. John M. Evans M.B.A.", "age": 47, "title": "CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1234010, "exercisedValue": 0, "unexercisedValue": 16127756}, {"maxAge": 1, "name": "Dr. Guiseppe  Ciaramella Ph.D.", "age": 56, "title": "President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1041270, "exercisedValue": 2506545, "unexercisedValue": 5912415}, {"maxAge": 1, "name": "Mr. Sravan Kumar Emany", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 617074, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christine P. Bellon J.D., Ph.D.", "age": 59, "title": "Senior VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 744950, "exercisedValue": 0, "unexercisedValue": 363849}, {"maxAge": 1, "name": "Dr. Amy  Simon M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 779170, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Feng  Zhang Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David R. Liu Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. J. Keith Joung M.D., Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Manmohan  Singh Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gopi  Shanker Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 29.29, "open": 29.0, "dayLow": 27.4389, "dayHigh": 29.04, "regularMarketPreviousClose": 29.29, "regularMarketOpen": 29.0, "regularMarketDayLow": 27.4389, "regularMarketDayHigh": 29.04, "payoutRatio": 0.0, "beta": 2.073, "forwardPE": -6.002273, "volume": 1667328, "regularMarketVolume": 1667328, "averageVolume": 1980740, "averageVolume10days": 1982930, "averageDailyVolume10Day": 1982930, "bid": 20.88, "ask": 35.23, "bidSize": 2, "askSize": 2, "marketCap": 2802737920, "fiftyTwoWeekLow": 13.525, "fiftyTwoWeekHigh": 36.44, "allTimeHigh": 138.522, "allTimeLow": 13.0, "priceToSalesTrailing12Months": 50.31755, "fiftyDayAverage": 27.6223, "twoHundredDayAverage": 22.1157, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1802352256, "profitMargins": 0.0, "floatShares": 87418364, "sharesOutstanding": 101474944, "sharesShort": 20044367, "sharesShortPriorMonth": 19788474, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.1975, "heldPercentInsiders": 0.012309999, "heldPercentInstitutions": 1.01749, "shortRatio": 11.03, "shortPercentOfFloat": 0.2219, "impliedSharesOutstanding": 101474944, "bookValue": 9.799, "priceToBook": 2.818655, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -414643008, "trailingEps": -4.41, "forwardEps": -4.60159, "enterpriseToRevenue": 32.358, "enterpriseToEbitda": -4.057, "52WeekChange": 0.14458776, "SandP52WeekChange": 0.16255379, "quoteType": "EQUITY", "currentPrice": 27.62, "targetHighPrice": 80.0, "targetLowPrice": 22.0, "targetMeanPrice": 47.21429, "targetMedianPrice": 43.5, "recommendationMean": 1.3125, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 14, "totalCash": 1074969984, "totalCashPerShare": 10.892, "ebitda": -444216000, "totalDebt": 151420000, "quickRatio": 5.888, "currentRatio": 6.017, "totalRevenue": 55701000, "debtToEquity": 15.675, "revenuePerShare": 0.593, "returnOnAssets": -0.23479, "returnOnEquity": -0.4719, "grossProfits": -356086016, "freeCashflow": -166764128, "operatingCashflow": -338177984, "revenueGrowth": -0.32, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -13.076, "financialCurrency": "USD", "symbol": "BEAM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": -5.701605, "regularMarketPrice": 27.62, "corporateActions": [], "postMarketTime": 1769821195, "regularMarketTime": 1769806802, "cryptoTradeable": false, "exchange": "NMS", "messageBoardId": "finmb_564610577", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Beam Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580999400000, "postMarketChangePercent": 0.65169585, "postMarketPrice": 27.8, "postMarketChange": 0.1799984, "regularMarketChange": -1.6700001, "regularMarketDayRange": "27.4389 - 29.04", "longName": "Beam Therapeutics Inc.", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1980740, "fiftyTwoWeekLowChange": 14.095001, "fiftyTwoWeekLowChangePercent": 1.0421443, "fiftyTwoWeekRange": "13.525 - 36.44", "fiftyTwoWeekHighChange": -8.819998, "fiftyTwoWeekHighChangePercent": -0.24204166, "fiftyTwoWeekChangePercent": 14.4587755, "earningsTimestamp": 1762263000, "earningsTimestampStart": 1762263000, "earningsTimestampEnd": 1762263000, "earningsCallTimestampStart": 1730813400, "earningsCallTimestampEnd": 1730813400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -4.41, "epsForward": -4.60159, "epsCurrentYear": -4.21959, "priceEpsCurrentYear": -6.5456595, "fiftyDayAverageChange": -0.002298355, "fiftyDayAverageChangePercent": -8.320651e-05, "twoHundredDayAverageChange": 5.504301, "twoHundredDayAverageChangePercent": 0.24888659, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "displayName": "Beam Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]